Sleep Well Despite Persistent Pain Symptoms
Background: The prevalence of comorbid insomnia is 8-10 times higher in patients with chronic pain than in the general population. Insomnia adds a considerable burden as it worsens the quality of life, restoration and repair, mental health and pain symptoms. Since pain and sleep problems are mutually reinforcing, impro
| Condition(s) | Insomnia Chronic, Insomnia Due to Medical Condition, Pain, Chronic |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Background: The prevalence of comorbid insomnia is 8-10 times higher in patients with chronic pain than in the general population. Insomnia adds a considerable burden as it worsens the quality of life, restoration and repair, mental health and pain symptoms. Since pain and sleep problems are mutually reinforcing, improvements in sleep may have beneficial effects on pain. Unfortunately, the customary use of sleep medication (TAU: treatment-as-usual) often yields short-lived plus side effects. The "Sleep-Well" intervention examines if a group-based intervention program focusing on sleep literacy, sleep restriction, stimulus control and metacognitive therapy modules may perform better than TAU in improving patients' insomnia and sleep quality. Eligible patients: Investigators target adult pat |
| Who can participate | Inclusion Criteria: * Patients who, after clinical examination at University hospital of Northern Norway (UNN) fill the criteria for a chronic non-malignant pain diagnosis according to ICD-10. * Satisfy criteria for a comorbid insomnia * Both first-time referrals and former referred patients. Exclusion Criteria: * A comorbid drug abuse diagnosis (ICD-10) * An ongoing compensation and/or insurance case related to a health issue, illness or treatment * Drug treatment using \>100 morphine equivalents * Participation in other group-based treatments at the UNN Pain Department or the Physical Outpatient Medical Clinic (must be completed before inclusion) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Lead sponsor | University of Tromso |
| Locations | Tromsø, Troms County, Norway |
| Start date | 2025-01-01 |
| NCT ID | NCT06351839 |
| Official listing | https://clinicaltrials.gov/study/NCT06351839 |